News
Breakthrough Victoria recaps a month of events across Victoria's innovation ecosystem
Breakthrough Victoria staff attended agrifood, climate finance, women's health and deep tech events, and joined the launch of agritech firm YieldX.
Investor · 2 deals
Jumar Bioincubator
Melbourne, VIC
Disclosed deals
Every published round Jumar Bioincubator took part in, and every parcel of existing shares it bought off another holder. Deals we hold but haven't published yet are not counted.
| Company | Stage | Announced | Amount | Role | Alongside | Sources |
|---|---|---|---|---|---|---|
| Misti | Accelerator | 15 Sep 2023 | - | Participant | Forbes Australia, Startup Daily | |
| Tessara Therapeutics Pty Ltd | Accelerator | undated | - | Lead | Forbes Australia, Startup Daily |
Portfolio
Companies Jumar Bioincubator has backed in a published round, and companies whose existing shares it bought off another holder.
| Company | What it does | First invested | Rounds | Led |
|---|---|---|---|---|
| Misti | 15 Sep 2023, Accelerator | 1 | 0 | |
| Tessara Therapeutics Pty Ltd | Accelerator | 1 | 1 |
Funds
Fund closes reported for Jumar Bioincubator, as distinct from the investments it has made.
Portfolio companies acquired
Companies Jumar Bioincubator has backed that another company then bought. An exit for the holding, not a deal Jumar Bioincubator did.
People
Coverage
Stories naming Jumar Bioincubator. Where several outlets covered the same round, they are bundled under whichever ran the fullest account.
News
CEO Message — One Year In
Breakthrough Victoria's chief executive marks his first year, tallying 70 investments, university and fellowship programs, a Jumar Bioincubator grant with partners, and looks ahead to a consolidated Victorian innovation entity.
News
From Vision to Impact: How Breakthrough Victoria Is Powering the State’s Innovation Economy
Breakthrough Victoria's CEO sets out the fund's investment record and an EY report finding its portfolio delivers strong returns and economic impact for Victoria.
Funding announcement
Meet Proxima Bio: Australia's next-generation biotech startup aiming to clean up cancer-causing proteins.
Profile of Australian biotech startup Proxima Bio, covering its founding, an early MRFF grant through the CUREator program, Brandon Capital's guidance, and a later larger investment that grew the team.
Grant
$3m
Meet 6 Aussie biotech startups vying to be the next CSL
A profile of six life-science ventures that graduated from Melbourne bioincubator Jumar's debut program, one of which, Tessara Therapeutics, won a $3 million research grant in December.
2 deals
Former Investible boss Rod Bristow signs on as Breakthrough Victoria's new CEO
Breakthrough Victoria, the Victorian government's $2bn investment fund, appoints Rod Bristow, previously Investible's CEO, as chief executive, succeeding inaugural CEO Grant Dooley. The article also recalls Seer Medical's administration.
Key hire
Breakthrough Victoria welcomes new CEO
Breakthrough Victoria has appointed Rod Bristow, previously Investible's CEO, as its chief executive, citing a 33-company portfolio, over $300 million invested and $1.06 billion attracted from co-investors.
Key hire
Rod Bristow Takes the Helm at Breakthrough Victoria, Poised for Growth and Impact
Breakthrough Victoria names Rod Bristow chief executive, citing his Investible and financial-services background, and outlines the fund's portfolio scale, co-investment record, and ambitions for patient capital and eventual exits.
5 deals
Breakthrough Victoria posts $3 million loss
The Victorian government's VC fund Breakthrough Victoria slipped to a loss, its annual report showing startup investments, cost cutting and boardroom departures amid criticism of its spending and performance.
Funding announcement
Breakthrough Victoria Follow On investments
Breakthrough Victoria reflects on its third annual report: over $350 million committed across 44 investments, including five follow-on investments worth over $35 million in the past financial year across five named portfolio companies.
3 deals
‘More than just a venture capital firm’: $2 billion sovereign fund Breakthrough Victoria hits back at critics who want it abolished
Breakthrough Victoria defends its spending and investment record against critics urging its abolition, pointing to portfolio companies, university partnerships and recent backing of startups including Aravax.
Funding announcement
Media release 21 March 2024
Breakthrough Victoria's media release marks three years, citing more than $300 million committed across direct investments, a fund, a grant and university partnerships, and discusses its Aravax and Seer Medical investments.
Fund close
$2b
End of year message from the CEO
Breakthrough Victoria's chief executive reviews the investment firm's first operating year, recalling backing for several startups, a university pre-seed fund platform, a quantum technology facility, and a new environmental challenge program.